symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
HCWB,1.91,1.153899,8165,68619997,0,1.08-2.42,0.08,HCW Biologics Inc.,USD,0001828673,US40423R1059,40423R105,NASDAQ Global Market,NASDAQ,Biotechnology,https://www.hcwbiologics.com,"HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. The company was incorporated in 2018 and is headquartered in Miramar, Florida.",Dr. Hing C. Wong Ph.D.,Healthcare,US,44,954 842 2024,2929 North Commerce Parkway,Miramar,FL,33025,,0,https://financialmodelingprep.com/image-stock/HCWB.png,2021-07-20,False,False,True,False,False
